| Followers | 200 |
| Posts | 25597 |
| Boards Moderated | 0 |
| Alias Born | 04/03/2010 |
Thursday, May 19, 2022 2:49:47 PM
The market is reactive, but at some point crying wolf doesn’t work anymore when there are better sources of information. So I believe that at some point, market appetite will take over and change the dynamics and a fairer price will be reflected in the share price.
Remember, now that results are somewhat leaked by the presentation, doctors at least in the U.K. are going to be far more likely to recommend and patients more likely to want to get DCVax-L now on a compassionate basis. Sawston, prior to approval may start generating some decently encouraging income even without the government paying for it.
I am not sure this will look like every other company at this same place where there is a factory, a super innovative new manufacturing process and revenue before approval. And certainly there will be more sources of news because of such u usual dynamics.
I am not sure where the price will go, but I would not bet on static pricing, and given where we are now and pending news some expected and probably some not, I do not believe the price is ultimately headed any lower, and certainly not for long periods if the news is all as expected.
Remember, now that results are somewhat leaked by the presentation, doctors at least in the U.K. are going to be far more likely to recommend and patients more likely to want to get DCVax-L now on a compassionate basis. Sawston, prior to approval may start generating some decently encouraging income even without the government paying for it.
I am not sure this will look like every other company at this same place where there is a factory, a super innovative new manufacturing process and revenue before approval. And certainly there will be more sources of news because of such u usual dynamics.
I am not sure where the price will go, but I would not bet on static pricing, and given where we are now and pending news some expected and probably some not, I do not believe the price is ultimately headed any lower, and certainly not for long periods if the news is all as expected.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
